During muscle relaxation, the \ \ \ \ covers the active site on actin. - MP NHM CHO-2024 (Shift-2)

MP NHM CHO-2024 (Shift-2)

Applied Physiology

Easy

Appeared in: MP NHM CHO-2024 (Shift-2)

Explanation

In a relaxed muscle, the myosin-binding sites on the actin filaments must be blocked to prevent unwanted contraction.
Tropomyosin is a long, fibrous protein that lies in the groove of the actin helix, directly covering these active sites.
This blockage prevents the formation of cross-bridges between actin and myosin, thus keeping the muscle in a relaxed state.
The position of tropomyosin is controlled by the troponin complex, which acts as a calcium-sensitive switch.

Option A: Myosin is the contractile protein that forms the thick filaments. Its heads bind to the active sites on actin to cause contraction; it does not cover them.
Option B: Titin is a large, elastic structural protein. Its function is to provide elasticity and stabilize the position of the thick (myosin) filaments, not to regulate the interaction between actin and myosin.
Option C: Troponin is a regulatory protein complex that binds to calcium ions. This binding causes a conformational change that moves tropomyosin away from the active sites. Troponin itself does not directly cover the active sites.

Visual 1: Diagram of the Sarcomere. An illustration showing the arrangement of thin (actin) and thick (myosin) filaments. A detailed view should highlight the troponin-tropomyosin complex on the actin filament, showing how tropomyosin physically blocks the myosin-binding sites in the relaxed state (low calcium) and moves away in the contracted state (high calcium).

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Physiology of Muscle Contraction and Relaxation as background academic context rather than a clinical decision trigger.
Understanding this mechanism is fundamental to comprehending pathologies like rigor mortis, where a lack of ATP prevents myosin heads from detaching from actin, leading to sustained muscle stiffness.
The regulation of muscle contraction is a target for various drugs, including muscle relaxants, which may act by interfering with calcium release or the actin-myosin interaction cycle.
What if? A mutation in the troponin complex that prevents it from properly controlling tropomyosin could lead to congenital myopathies, characterized by either muscle weakness or hyper-contractility, depending on the nature of the defect.

How to Approach the Question

First, identify the key process in the question: 'muscle relaxation'. This implies a state where contraction is inhibited.
Next, recall the main proteins involved in muscle contraction: contractile proteins (actin, myosin) and regulatory proteins (troponin, tropomyosin).
Consider the function of each option in the context of relaxation. Relaxation requires preventing the interaction between actin and myosin.
Analyze the roles: Myosin is the 'motor', Titin is a 'spring', Troponin is the 'calcium-sensor switch', and Tropomyosin is the 'physical blocker'.
The question asks what 'covers the active site'. This directly corresponds to the function of tropomyosin, which acts as a physical barrier between actin and myosin in the resting state.

Concept Tested & Keywords

QZ2LfBgVTClAqZgaC0jexV